Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Infection”

Showing 12 of 0 results

Not applicableUnknownNCT05471635
What this trial is testing

Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)

Who this might be right for
COVID-19 Vaccines
Alberto Peano 205
Not applicableWithdrawnNCT05234398
What this trial is testing

TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted Patients

Who this might be right for
Solid Organ Transplant Recipients
Hospices Civils de Lyon
Large-scale testing (Phase 3)UnknownNCT04323228
What this trial is testing

Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19

Who this might be right for
COVID-19
King Saud University 40
Not applicableUnknownNCT05667714
What this trial is testing

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 2,900
Early research (Phase 1)Ended earlyNCT04401410
What this trial is testing

Anti-SARS Cov-2 T Cell Infusions for COVID 19

Who this might be right for
SARS-CoV 2Viral InfectionCOVID 19
Baylor College of Medicine 4
Large-scale testing (Phase 3)Ended earlyNCT04707703
What this trial is testing

Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Aspergillosis Invasive
Jeffrey Jenks, MD, MPH 8
Not applicableStudy completedNCT04757792
What this trial is testing

Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU

Who this might be right for
COVID-19 Disease
Benha University 475
Post-approval studies (Phase 4)Study completedNCT05087381
What this trial is testing

Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community

Who this might be right for
Treatment Efficacy
Chulalongkorn University 1,200
Testing effectiveness (Phase 2)Study completedNCT04359810
What this trial is testing

Plasma Therapy of COVID-19 in Severely Ill Patients

Who this might be right for
SARS-CoV-2 Infection
Max O'Donnell 223
Not applicableStudy completedNCT05358873
What this trial is testing

Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail

Who this might be right for
SARS CoV 2 InfectionSARS-CoV-2 Acute Respiratory Disease
Chulalongkorn University 50
Not applicableNo Longer AvailableNCT04346277
What this trial is testing

Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)

Who this might be right for
COVIDARDS, HumanArds+1 more
Implicit Bioscience
Not applicableStudy completedNCT06597370
What this trial is testing

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population

Who this might be right for
COVID-19 Vaccine
National Polytechnic Institute, Mexico 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation